This approach saves time and reduces the hassle of traditional doctor visits
It may involve Medicare negotiating the price for semaglutide with Novo Nordisk, or having insurers pay for it using a subscription model, similar to what was done for hepatitis C treatments when they were first released
However, clinical trials have shown that patients taking Semaglutide GLP-1 can lose an average of 10-15% of their body weight over a period of several months
Some medications to watch out for include: Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL) Wegovy causes a delay in gastric emptying, so it has the potential to impact the absorption of medications that are taken by mouth at the same time
Second, confounding by indication is likely, as GLP-1 RAs are prescribed primarily to individuals with type 2 diabetes or obesity, who differ from lithium-treated patients in metabolic risk, renal surveillance intensity, and access to nephrology care
